SABITALKS / Multiomics Techniques in Pancreatic Cancer ResearchSABITALKS / Multiomics Techniques in Pancreatic Cancer ResearchSABITALKS / Multiomics Techniques in Pancreatic Cancer ResearchSABITALKS / Multiomics Techniques in Pancreatic Cancer Research
  • RESEARCH CENTERS
  • CORE FACILITIES
    • Advanced Microscopy
    • Cell Culture
    • Molecular Cell Biology
    • Proteomics
    • Drug Discovery
    • Bioinformatics
    • Biomaterials
    • Electrophysiology and Behavior
    • Cognitive Neuroscience
    • Animal House
  • PEOPLE
    • Administration
    • Group Leader
    • Transition Scientist
    • Early Career Researchers
    • Students
  • EVENTS
    • Event Calendar
    • Critical Mind
    • SABITALKS
    • InFocus
    • CROSSTALKS
    • MODAS WS
    • SABITA Podcast
    • Social
  • ABOUT US
    • Our Mission
    • Gender Equality Policy
  • RESEARCH CENTERS
  • CORE FACILITIES
    • Advanced Microscopy
    • Cell Culture
    • Molecular Cell Biology
    • Proteomics
    • Drug Discovery
    • Bioinformatics
    • Biomaterials
    • Electrophysiology and Behavior
    • Cognitive Neuroscience
    • Animal House
  • PEOPLE
    • Administration
    • Group Leader
    • Transition Scientist
    • Early Career Researchers
    • Students
  • EVENTS
    • Event Calendar
    • Critical Mind
    • SABITALKS
    • InFocus
    • CROSSTALKS
    • MODAS WS
    • SABITA Podcast
    • Social
  • ABOUT US
    • Our Mission
    • Gender Equality Policy

SABITALKS / Multiomics Techniques in Pancreatic Cancer Research

Dr. Büşra Köse Demirtaş from University of Oklahoma is going to be at SABITALKS on September 9, 2024 at 10:00. The event will take place in person. You can attend the event in person in Lecture Hall C-412.

Location: Istanbul Medipol University Kavacık North Campus: https://goo.gl/maps/JDDjygVtFLWiPiMJA

*Participants from outside SABITA must fill in the participation form.

SABITALKS PARTICIPATION FORM

Multiomics Techniques in Pancreatic Cancer Research

Multi-omics involves bringing the multiple “omics” techniques together, to get a more comprehensive picture of biological processes, and disease pathology, and identify more robust drug targets and biomarkers. Today, mass spectrometry technology offers a morphologically-friendly approach to analyzing biological materials as imaging mass spectrometry (IMS) is a method that provides spatial as well as chemical information bridging the gap between anatomy and physiology in a wide range of biological problems including cancer.

Büşra Köse Demirtaş

Dr. Büşra Köse Demirtaş

University of Oklahoma

[email protected]

Have experience and knowledge surrounding cancer biology, also, have been studying multiomics studies by using liquid chromatography and mass spectrometry techniques since 2019.
Took Bachelor’s degree in Molecular Biology and Genetics, and Master’s degree in Medical Biology and Genetics, and got Ph.D. in Biochemistry and Molecular Biology. Studied cancer, proteomics, cancer screening and development of early diagnosis markers at many well-known institutes in Turkey, and also, several short-term roles abroad as a visiting researcher.
Accomplished the Ph.D. program and started to work at Stephanson Cancer Center, University of Oklahoma as a Postdoctoral Research Fellow in July 2023 have been studying metabolism of pancreatic cancer by using multi-omics and imaging mass spectrometry approaches.

Share

SOCIAL MEDIA

SHORTCUT LINKS

 

  • Contact
  • Corporate Identity
  • Referrence Guide
  • Request Forms
  • Sabita 360°
  • Sabita Society
  • Social

OUR MISSION

Translation of Scientific Findings From Bench to Bedside

  • Read More
  • © 2025 Medipol University | SABITA Research Institute for Health Sciences and Technologies
    [contact-form-7 id="50" title="Contact form 1"]